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The stable expression of reporter genes in adult stem cells (ASCs) has important applications in stem cell biology. The ability to
integrate a noncytotoxic, ﬂuorescent reporter gene into the genome of ASCs with the capability to track ASCs and their progeny is
particularly desirable for transplantation studies. The use of ﬂuorescent proteins has greatly aided the investigations of protein and
cell function on short-time scales. In contrast, the obtainment of stably expressing cell strains with low variability in expression
for studies on longer-time scales is often problematic. We show that this diﬃculty is partly due to the cytotoxicity of a commonly
used reporter, green ﬂuorescent protein (GFP). To avoid GFP-speciﬁc toxicity eﬀects during attempts to stably mark a rat hepatic
ASC strain and, therefore, obtain stable, long-term ﬂuorescent ASCs, we evaluated cyan ﬂuorescent protein (CFP) and yellow ﬂu-
orescent protein (YFP), in addition to GFP. Although we were unable to derive stable GFP-expressing strains, stable ﬂuorescent
clones (up to 140 doublings) expressing either CFP or YFP were established. When ﬂuorescently marked ASCs were induced to
produce diﬀerentiated progeny cells, stable ﬂuorescence expression was maintained. This property is essential for studies that track
ﬂuorescently marked ASCs and their diﬀerentiated progeny in transplantation studies.
Copyright © 2008 R. R. Taghizadeh and J. L. Sherley. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1. INTRODUCTION
Fluorescent proteins have become widely used as markers for
positively identifying and tracking expressing cells in many
in vitro and in vivo studies. The most widely used, green ﬂu-
orescent protein (GFP), cloned from Aequorea victoria,d o e s
not require substrates or cofactors and can be used in a va-
riety of species [1, 2]. Among its various uses as a marker,
GFP has been used for transient studies of cell apoptosis
[3], cytoskeletal dynamics [4], and inhibitory gene expres-
sion [5]. Since no cofactors are needed for the native GFP
protein to develop ﬂuorescence, it has been possible to use it
as a marker in many diﬀerent organisms. For instance, trans-
genic Drosophila melanogaster [6], zebraﬁsh [7, 8], mice [9–
12], and rats [13, 14] have been successfully derived using
wild-type GFP. Although successful in obtaining stable GFP-
expressing transgenic animals, attempts to develop in vitro-
cell lines stably expressing GFP have been largely unsuccess-
ful [2, 3, 15–18].
Currently, in adult stem cell (ASC) research, there is a
critical need for methods to verify ASCs in vitro and track
their progeny in in vivo repopulation studies. Since mark-
ers that uniquely identify ASCs are unknown, the accepted
method to conﬁrm the “stemness” of a cell population is
by transplantation of cells into animals after injury to tar-
geted tissues. If ASCs are present at signiﬁcant levels in the
transplanted cell population, the animal survives with repair
of the damaged tissue. However, in these experiments, there
is uncertainty as to whether the tissue has been repaired by
the transplanted cells, by activated resident host ASCs, or by
host cells recruited from another tissue source altogether. To
overcome these uncertainties, methods to identify the trans-
plantedcellsandtheirdescendentshavebeenapplied.Ideally,
these methods need to identify donor cell progeny indepen-
dent of subsequent diﬀerentiation status.
Though attractive as an in vivo tracking tool in ASC re-
population assays, GFP has several drawbacks. One short-
coming of GFP is that it can induce cell death. Intense exci-
tation of the protein in vitro for extended periods can gener-
ate free radicals that are quite toxic to cells [15]. The inabil-
ity to obtain constitutively expressing GFP cell strains may
also be related to DNA methylation eﬀects. In the presence2 Journal of Biomedicine and Biotechnology
ofanirreversibleinhibitorofmethyltransferase,C3Ahuman
hepatoblastoma cells transfected with GFP showed a signif-
icantly greater retention of GFP expression and exhibited
higher levels of GFP production [19]. As a result, GFP has
been more successfully used extensively as a viable marker
for mostly short-time scale experiments (hours), whereas at-
tempts to establish long-term (months) GFP-expressing cell
strains have been mostly unsuccessful [2, 3, 15–18]. The
reported eﬃciency of establishing stable, constitutively ex-
pressing cell lines is extremely low [18].
GFP-expressing transgenic mice are readily available [9–
12] and are a possible source for GFP-labeled cells. These
mice are uniformly green with the exceptions of hair and red
blood cells. However, there are still barriers to their use as a
source of ﬂuorescently marked ASCs. One major drawback
is that, for many tissues, methods do not exist for eﬃcient
isolation of ASCs. Additionally, GFP-transgenic mice do not
oﬀer a solution for tracking ASCs derived from other species
for which transgenic technology has not been developed.
Due to similar diﬃculties in developing ASCs with con-
stitutive GFP expression, we evaluated two variants of GFP,
cyan ﬂuorescent protein (CFP) and yellow ﬂuorescent pro-
tein (YFP) that have diﬀerent excitation-emission proﬁles
and, therefore, may have less toxicity associated with their
free-radical byproducts. An early screen of A. victoria mu-
tants produced CFP which has an emission spectrum below
thatofGFPduetoaTyr66 to Trp66 substitution[20,21].Sim-
ilarly, YFP has been rationally designed on the basis of the
GFP crystal structure to red-shift the absorbance and emis-
sion spectra with respect to GFP. Based on these diﬀerences,
we evaluated whether CFP and YFP might allow for stable,
long-term ﬂuorescence in rat hepatic ASCs derived in our
laboratory. We were able to establish stable, long-term ex-
pressing ASC strains. When these ﬂuorescently marked ASCs
were induced to produce diﬀerentiated progeny cells, stable
expression of ﬂuorescence was maintained. Our ﬁndings in-
dicate that CFP and YFP are more suitable markers for ASC
studies in vitro and predict that they will be better markers
f o ri nv i v os t u d i e s ,a sw e l l .
2. MATERIALS AND METHODS
2.1. Cells
Previously derived [22] rat hepatic ASC strain, Lig-8, was
maintained in Dulbecco’s Modiﬁed Eagle Medium (DMEM;
Life Technologies, Carlsbad, Calif, USA) supplemented with
10% dialyzed fetal bovine serum (DFBS, JRH Biosciences,
Lenexa, Kan, USA), 1% Penicillin/Streptomycin (Life Tech-
nologies, Carlsbad, Calif, USA), and 400μM xanthosine (Xs;
Sigma-Aldrich, St. Louis, Miss, USA) in a 37◦C humidiﬁed
incubator with a 5% CO2 atmosphere.
2.2. Plasmids
Ampliﬁed plasmids for transfection were isolated by Qiagen
(Valencia, Calif, USA) column fractionation as speciﬁed by
the supplier and further puriﬁed by cesium chloride equilib-
riumdensitygradientcentrifugation.Transfectionswereper-
formed using 5μg of pEGFP-N3 vector plasmid (Clontech
Laboratories, Palo Alto, Calif, USA) under the control of a
cytomegalovirus (CMV) promoter. In addition, the pEGFP-
N3 vector contains a neomycin resistance gene insert under
the control of the simian virus-40 (SV40) promoter confer-
ring resistance to the antibiotic GenetecinTM (Life Technolo-
g i e s ,C a r l s b a d ,C a l i f ,U S A ) .T h eC F Pa n dY F Pd e r i v a t i v e so f
pEGFP-N3werepreparedbydigestionandcompleteremoval
of the EGFP insert using BamH1 and Not1 endonucleases
(New England Biolabs, Beverly, Mass, USA). The respective
CFP or YFP insert was ligated into the vector after gel pu-
riﬁcation. Additional vectors used to attempt to derive sta-
ble GFP expressing cells included pCX-EGFP (supplied by
B. Engleward, Massachusetts Institute of Technology) and
pEGFP-N1 (Clontech Laboratories, Palo Alto, Calif, USA).
pCX-EGFP regulates EGFP (enhanced GFP) under a chicken
beta-actin promoter/CMV-IE enhancer and pEGFP-N1 is a
sequence variant of pEGFP-N3.
2.3. Transfection
Lig-8 cells were seeded at 1/10 conﬂuency in a 75-cm2 ﬂask
(Corning, Corning, NY, USA) one day prior to transfection.
Lig-8cellswerethenindependentlytransfectedwiththeCFP,
YFP, or GFP expression plasmids using Cytofectene (BioRad
Laboratories, Hercules, Calif, USA), per manufacturer’s sug-
gested instructions. Approximately, 1.5 × 106 cells (1/5 con-
ﬂuency in 75-cm2 ﬂask) were transfected for 16–20 hours
and then given two phosphate buﬀer saline (PBS) washes,
followed by supplementation with regular growth medium.
The transfected cells were cultured for an additional 42–48
hours. After this time period, the transfected cells were re-
plated at 1/6 density in parallel in 10-cm diameter plates
(Corning, Corning, NY, USA). After overnight culture, the
culture medium was replaced with medium supplemented
to 0.5mg/ml GenetecinTM to select for stably transfected cell
clones.
2.4. Clonalcellviability
Propidium iodide (PI; Sigma, St. Louis, Mo, USA) was added
directlytomediaandcellsat5μg/mltodetermineviabilityof
clonal cells. A Nikon super high-pressure mercury lamp was
used to image PI cells using a Nikon epiﬂuorescent micro-
scope.
2.5. Derivationofﬂuorescent
protein-expressingclones
A f t e r1 4d a y si nc u l t u r e ,t r a n s f e c t e dc e l l sf r o me a c h1 0 - c m
diameter plate were trypsinized and each transferred into a
75-cm2 ﬂask with selection medium maintained thereafter.
After two days, the transfected cells were reseeded at 1000
cells each into ﬁve individual 10-cm diameter dishes. Re-
sistant colony formation was assessed after 10–14 days of
culture in selection medium, with medium changes every 3
days. After this time, colonies were counted and scored as
nonexpressing (B1; 0% of cells in the colony were expressing
ﬂuorescent protein), semiexpressing (B2; estimated 25–75%
of cells in the colony were expressing ﬂuorescent protein)R. R. Taghizadeh and J. L. Sherley 3
Table 1: Relative transfection eﬃciency of ﬂuorescent gene markers and cloning eﬃciency of selected transfected cell colonies. Transfection eﬃ-
ciency is deﬁned as the average number of colonies/estimated number of cells transfected/μg DNA. Transfections included ∼1.5 × 106 cells.
Cloning eﬃciency is deﬁned as the number of stable cell strains derived/number of colonies cultured.
Fluorescent
marker
Average colony
number/10-cm
dish
Relative transfection
eﬃciency
Number of
clones picked
Number of Stable
cell strains derived Cloning eﬃciency
GFP 1.3 (n = 10) 0.02 8 0 0%
CFP 64 (n = 3) 1.00 6 6 100%
YFP 61 (n = 3) 0.95 6 6 100%
Colony number 13
Colony number 9
Colony number 6
Colony number 12
Colony number 8
Phase GFP PI GFP/PI merge
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Figure 1: Transient, short-term GFP ﬂuorescence expression by the rat hepatic ASC strain, Lig-8, is associated with cell death. Cell strain, Lig-8,
was transfected with the pEGFP-N3 expression vector. Shown are images of 5 independent colonies transiently expressing GFP ﬂuorescence
at 72–96 hours posttransfection. Shown are the phases (a)–(e), GFP-ﬂuorescence (f)–(j), propidium iodide (PI) ﬂuorescence (k)–(o), and
merged GFP and PI ﬂuorescence (p)–(t) images. Arrows highlight speciﬁc examples of cells double-positive for GFP and PI ﬂuorescence in
Colony no. 12. Scale bar is equivalent to 100μm.
or fullyexpressing (B3; ∼100% of the cells in the colony
were expressing ﬂuorescent protein). Several well-separated
colonies were isolated within cloning cylinders (Bellco Glass,
Vineland, NJ, USA), harvested by trypsinization, transferred
to 25-cm2 ﬂasks (Corning, Corning, NY, USA), and allowed
toexpandfor10–14days,untiltheﬂaskwas>90%conﬂuent.
At that point, cells from the 25-cm2 ﬂasks were trypsinized
and transferred into a 75-cm2 ﬂask. Within 3-4 days, the
ﬂasks were 90% conﬂuent. After trypsinization, ∼80% of the
cells in cultures of expanded clones were frozen in liquid ni-
trogen [22] for early passage stocks. All expanded clones ex-
hibited respective CFP or YFP ﬂuorescence expression for
at least 15 population doublings before being cryogenically
stored. The remaining cells were maintained in culture and4 Journal of Biomedicine and Biotechnology
passaged for at least 24 weeks (estimated 140 population
doublings). Three of the CFP-expressing Lig-8 clonal strains,
B1, B2, and B3, were subsequently evaluated for this study.
Population doublings were determined based on the esti-
mated total number of cells produced over time with the ex-
ponentialgenerationtimeof ∼18hoursdeterminedforLig-8
parent cells.
2.6. Flowcytometryandﬂuorescencemicroscopy
A FACStar Plus ﬂow cytometer (Becton, Dickinson and
Company, Franklin Lakes, NJ, USA) was used to quantify
the fraction of ﬂuorescent cells in populations. The FAC-
Star Plus was equipped with two coherent Innova 90 lasers
for visible and ultraviolet argon lines. Data acquisition and
analyses were performed with CellQuest software (Becton,
Dickinson and Company, Franklin Lakes, NJ, USA) and
Summit analyses software (Cytomation, Inc., Fort Collins,
Colo), respectively. The nontransfected parent Lig-8 ASC
s t r a i nw a su s e da san e g a t i v ec o n t r o lf o ra l la n a l y s e st oa c -
countforbackgroundcellautoﬂuorescence.Cellpopulations
were analyzed using both ﬂow cytometry and epiﬂuores-
cence microscopy using a Nikon TE300 microscope system
with DAPI/GFP/CFP/YFP ﬁlters. A Hamamatsu digital cam-
era and OpenLab imaging system were used for digital imag-
ing. The Student’s t test was used to determine the statistical
conﬁdence of observed diﬀerences in ﬂuorescence.
2.7. Differentiationinduction
Cells were treated for 9 days with 20ng/ml epidermal growth
factor (EGF) and 0.5ng/ml transforming growth factor b
(TGF-b) (Life Technologies, Carlsbad, Calif, USA), in the
same culture medium, except that the DFBS was reduced to
1%. The details of the diﬀerentiation induction protocol will
be reported elsewhere [23].
3. RESULTS
Using CFP, YFP, or GFP as independent ﬂuorescent pro-
tein markers, we transfected respective expression plasmids
into a previously described rat hepatic ASC strain, Lig-8
[22]. Asymmetric selfrenewal associated with production of
diﬀerentiated progeny cells is the deﬁning feature of ASCs
[22, 24]. Lig-8 cells were derived based on their asymmetric
cell kinetics [22, 24]. Lig-8 cells asymmetrically self-renew
and produce diﬀerentiated progeny with mature hepatocyte
properties [22, 23, 25]. The diﬀerentiated progeny cells ex-
press transcription factors and protein antigens that are spe-
ciﬁc for hepatocyte development and maturation, respec-
tively. Hepatocyte-speciﬁc phenotypes include binucleation,
albumin secretion, and expression of inducible cytochrome
P450s [22, 23, 25]. Based on well-deﬁned ASC properties,
Lig-8 cells were ideal for evaluation of eﬀects of GFP, CFP,
and YFP in ASCs.
We found that transfections with GFP gene constructs
yielded transfected colonies ∼50-fold less eﬃciently than
transfections with the analogous CFP- or YFP-gene con-
structs (Table 1). In addition, colonies of GFP-transfected
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Figure 2: Stable, long-term expression of CFP ﬂuorescence in sta-
bly transfected rat hepatic ASC clones. Three cell clones expanded
from CFP-transfected colonies, B1, B2, and B3 (as described in
text), were propagated and serially analyzed for CFP expression. At
the indicated number of population doublings, the percentage of
ﬂuorescence-expressing cells was determined by ﬂow cytometry for
each speciﬁed clone. The cells have been passaged for a maximum
of 140 population doublings.
cells could not be propagated as stable cell strains, whereas
both CFP- and YFP-transfected cell colonies had 100%
cloning eﬃciency (Table 1). Furthermore, we determined
that cells that were transiently-expressing GFP appeared to
undergo cell death, as GFP-expressing cells were also posi-
tive for propidium iodide (PI) (Figure 1). PI is impermeable
to intact membranes but readily penetrates the membranes
of nonviable cells and binds to DNA and RNA, causing red
ﬂuorescence. The cells eventually rounded up and detached
fromtheculturedish,whilestillshowingGFPandPIﬂuores-
cence (Figure 1, colonies 6, 9, and 13). Similar observations
were made with Lig-8 cells transfected with pCX-EGFP and
pEGFP-N1 plasmids. All observed GFP-expressing colonies
yielded this same fate (data not shown).
Expanded CFP and YFP clones expressed the respective
ﬂuorescent proteins stably for at least 24 weeks in culture
(∼140 doublings; e.g., clone B3 in Figure 2). Clones that
were successfully derived exhibited a range of CFP- or YFP-
expressing cell fractions. As a result, these clones were char-
acterized as nonexpressing (B1; 0% of cells in the colony ex-
press ﬂuorescent protein, data not shown), semiexpressing
(Figure 3, B2; at least 25–75% of cells in the colony expressed
ﬂuorescentprotein,butnotall);orfullyexpressing(Figure 3,
B3; approximately 100% of the cells in the colony expressed
ﬂuorescent protein). Although cell strains were derived from
both CFP and YFP expressing colonies, only CFP cell strains
were further evaluated.
Although, as colonies, the CFP-expressing cell strains
exhibited the ﬂuorescent properties described, with further
propagation in culture, the ﬂuorescence for one of the trans-
fected clones decreased (B2 in Figure 2). Moreover, cellsR. R. Taghizadeh and J. L. Sherley 5
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Figure 3: Fluorescent protein (CFP or YFP)-expressing colonies from rat hepatic ASCs. Rat hepatic ASC strain, Lig-8, was stably transfected
with either a CFP or YFP expression vector. Shown are colonies with approximately 20–75% of the cells expressing (B2) and colonies with
essentially 100% of the cells expressing (B3). Shown are the phases (a)–(d), ﬂuorescent (e)–(h), and merged (i)–(l) images of CFP- and
YFP-expressing colonies. Scale bar is equivalent to 100μm.
derived from an initially non-expressing B1 colony began to
express CFP (Figure 2; B1) at levels comparable to continu-
ously, fully-expressing B3 clones (Figure 2; B3) during clonal
propagation. Qualitatively, the B2 and B3 CFP-expressing
clones maintained their initially observed ﬂuorescent prop-
erties. Although there was some variation in expression seen
in the early stages of clonal analysis, expression stabilized
with propagation, and low variability was observed for at
least 24 weeks (estimated 140 population doublings). The B2
cell clone exhibited the greatest ﬂuctuation in ﬂuorescence
expression (Figure 2), but did not change in its basic charac-
ter of expressing CFP.
Stable ﬂuorescent protein expression did not alter the
essential properties of the parent hepatic ASC strain, Lig-8
(data not shown). We have found that, because of their asym-
metric self-renewal property, the parent Lig-8 hepatic ASCs
are resistant to complete diﬀerentiation by TGF-β,E G F ,a n d
serum deprivation [23]. Under conditions of TGF-b supple-
mentation,Lig-8cellsproducediﬀerentiatedprogenycellsby
asymmetric cell divisions that allowed them to retain their
undiﬀerentiated ASC state [23]. To evaluate CFP expression
in diﬀerentiated progeny cells, the three CFP-expressing ﬂu-
orescent ASC strains (B1, B2, and B3) were examined af-
ter culture under EGF/TGF-β-induced diﬀerentiation con-
ditions. All strains exhibited similar morphological and cell
kinetic properties observed for the nontransfected parental
Lig-8 strain (data not shown). As shown in Figure 4,u n d e r
normal conditions, the B3 cell clone exhibited uniform cell
morphology (a)–(c), whereas under diﬀerentiation condi-
tions, a heterogeneous collection of varying morphological
cell types appeared. Some diﬀerentiated cells had a notice-
able larger size and altered morphology (Figure 4, (d)–(f);
arrows), compared to cells under normal culture conditions.
After induction of diﬀerentiated progeny, the CFP-
ﬂuorescent cell fraction of B1 cells did not vary signiﬁcantly
relative to the routine (undiﬀerentiated) culture conditions
(Table 2). However, although exhibiting stable ﬂuorescence
expression under diﬀerentiating conditions, B1 and B3 cell
clones displayed a statistically signiﬁcant increase (60%, P<
.01; and 91%, P<. 002, resp.) in median ﬂuorescence per cell6 Journal of Biomedicine and Biotechnology
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Figure 4: Qualitative comparison of CFP-ﬂuorescent B3 cells under control and diﬀerentiating culture conditions. Clone B3 cells were
cultured under routine (control) (a)–(c) or diﬀerentiating (d)–(f); 20ng/ml epidermal growth factor, 0.5ng/ml transforming growth factor
b, 1% serum) culture conditions for 9 days. Shown are phases (a), (d), ﬂuorescent (b), (e), and merged (c), (f) images. Arrows indicate
morphologically diﬀerentiated cells. Scale bar is equivalent to 100μm.
Table 2: Quantitative comparison of the CFP-ﬂuorescent cell frac-
tions of cultures under undiﬀerentiated and diﬀerentiated condi-
tions. Flow cytometry quantiﬁcation of the R2 region of ﬂow his-
tograms(see,e.g.,inFigure 5)forthreeﬂuorescentcellclones(same
as Figure 2). Data are the average % ﬂuorescent cells at 24 weeks in
cultures ± standard deviation (SD). Cells were analyzed under nor-
malcultureconditions(undiﬀerentiated)andunderconditionsthat
increase diﬀerentiated progeny (diﬀerentiation), as described in the
text.
% CFP ﬂuorescence (mean ± SD; n = 2) condition
Strain Undiﬀerentiated Diﬀerentiated
B1 94 ± 0.02 94 ± 0.88
B2 33 ± 1.6 28 ± 0.87
B3 87 ± 0.32 79 ± 2.3
under diﬀerentiating conditions (see also Figure 5 for FACS
histogram of B3 clone). The B2 and B3 cell clones showed
only modest (15% and 9%, resp.), albeit statistically signiﬁ-
cant (P<. 03 and P<. 02, resp.), reductions in ﬂuorescent
cell fractions (Figure 5; Table 2). Thus, although the three
cell strains were derived from three independent clones and
displayed diﬀering ﬂuorescent cell fractions (Figure 3), their
ﬂuorescence fraction did not vary by more than 15% when
diﬀerentiated progeny cells were produced. The estimated
fraction of diﬀerentiated progeny under these conditions is
≥ 80% [23], indicating that a majority of diﬀerentiated cells
retain a high level of ﬂuorescence.
4. DISCUSSION
This report is a ﬁrst study to look at GFP-, CFP-, and
YFP-transgenes in side-by-side experiments in the same
ASC strain. We evaluated the use of these transgenes for
the derivation of stable, long-term ﬂuorescence-expressing
rat hepatic ASC clones. We were able to attain transient
GFP-expressing cells, but due to either the toxicity and/or
methylation associated with GFP, were unable to propa-
gate these clones as stable, long-term GFP-expressing hep-
atic ASC strains. Given the failure to even establish clones
from colonies with extinguished GFP ﬂuorescence, cytotoxi-
city seems to be the primary problem.
GFP gene transfections gave rise to transient express-
ing cells for up to 72–96 hours posttransfection. As culture
continued, intact, adherent cells positive for GFP-expression
began to round up, detach, and lose viability, as indicated
by propidium iodide (PI) staining. Eventually, all adherent,
GFP-expressingcellsroundedup,detached,andbecamepos-
itive for PI staining. These experiments were performed with
three diﬀerent GFP plasmid constructs (pEGFP-N3, pCX-
EGFP,andpEGFP-N1).However,innocasewerestableGFP-
expressingcellstrainsobtainable.Theseobservations,cumu-
latively, indicate that the GFP protein is toxic to the cells.
Other studies [15, 16] have obtained similar results using
various GFP expression plasmids. One group in particular
[15] examined several variants of GFP plasmids resulting in
many of the GFP-expressing cells contracting, rounding up,
and dying, which was conﬁrmed by decreasing luciferase ac-
tivity and increasing CPP32-activity, a cysteine protease that
plays a direct role in the proteolytic digestion of cellular pro-
teins responsible for progression to apoptosis.
Our work with GFP conﬁrms that the GFP protein prod-
uct has toxic side-eﬀects in at least one type of ASC, whereas
the CFP and YFP protein, translated from the same plas-
mid vector construct is well tolerated by these cells. This
conclusion can also explain the transfection eﬃciency and
cloning eﬃciency data from our analyses. Since stable trans-
fection eﬃciency is an indicator of the success for the trans-
fer and integration of genes into cells, it is likely that due to
GFP-related toxicity, both CFP- and YFP-genes transfectedR. R. Taghizadeh and J. L. Sherley 7
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Figure 5: CFP-ﬂuorescence expression of the rat hepatic ASC clone
B3 is stable after induction of diﬀerentiation. Flow cytometry analy-
sis was performed with cultures of the nontransfected parental rat
hepatic ASC strain, Lig-8 (a), and CFP-ﬂuorescent clone B3 hepatic
ASC cultures. The B3 cells were evaluated under routine (b) and
diﬀerentiating (c) culture conditions. Histograms plot the relative
numbers of cells as a function of the log-relative CFP ﬂuorescence
per cell. The background ﬂuorescence, as deﬁned by nontransfected
Lig-8 cells is depicted as the R1 region, and positive ﬂuorescence
is denoted by the R2 region. Numbers indicate the percent of cells
positive for CFP ﬂuorescence expression.
the hepatic ASCs ∼50-fold better than the analogous GFP
gene. Cloning eﬃciency data further conﬁrms the diﬃcul-
ties observed with stable, long-term transduction with GFP;
since 100% of CFP- and YFP-clones gave rise to cell strains,
whereas none of the GFP-derived colonies gave rise to sta-
ble clones. Examined CFP-expressing clones B1, B2, and B3
retained a high level of ﬂuorescent expression at 24 weeks
of culture (approximately 140 population doublings), even
though one of the clones (B1) initially showed decreasing ex-
pression. Altogether, these observations suggest further ev-
idence that due to GFP-dependent toxicity, GFP cannot be
utilizedasastableﬂuorescentreporterinthesehepaticASCs.
When the CFP-expressing cell strains (B1, B2, and B3)
were placed under diﬀerentiation conditions after 120 dou-
blings, either no or only modest reductions in ﬂuorescence
cell fractions were observed relative to normal culture condi-
tions. However, although exhibiting stable ﬂuorescence ex-
pression under diﬀerentiating conditions, B1 and B3 cells
displayed astatisticallysigniﬁcant increase in the median ﬂu-
orescence of positive cells. This increase in median ﬂuores-
cence may be directly related to an increase in the median
cell size of the population, since it has been observed that
asLig-8cellsdiﬀerentiate,they producelargehepatocyte-like
cells [23].Nonetheless,thisstabilityinﬂuorescenceisimpor-
tant, since it suggests that CFP is expressed independent of
the diﬀerentiation state of progeny cells. Stable ﬂuorescence
expression in our in vitro diﬀerentiation studies is a predic-
torofstableexpressionininvivodiﬀerentiation,sinceTGF-b
is a ubiquitous diﬀerentiation growth factor, especially in the
liver [26]. The high stability in ﬂuorescence expression un-
der both normal and diﬀerentiating conditions can ideally
be used in transplantation studies to evaluate the in vivo re-
population properties of these cells.
The importance of this report is underscored by re-
ports concluding statistically signiﬁcant ampliﬁcation of
hematopoietic stemcells(HSCs) byforcedexpression ofspe-
ciﬁc genes. For instance, the gene transfer of the HOXB4
gene into human hematopoietic stem cells was reported to
result in an overall approximately 2-fold increase in total and
CD34+ cells, normalized to a transfer of a control EGFP gene
construct [27]. This 2-fold increase and eventual signiﬁcant
overall increase in in vivo repopulation eﬃciency caused by
HOXB4 regulation could be interpreted as the result of in-
creased cell death in EGFP-controls due to ﬂuorescent toxic-
ity and not due to the expansion of HSCs using HOXB4 reg-
ulation, as suggested. Similarly, in another report using re-
combinant HIV transactivating (TAT)-HOXB4 protein [28],
TAT-GFP was used as a control for the in vivo expansion
and pluripotency of HSCs. It was concluded that TAT-GFP
was ineﬀective in supporting HSC expansion, whereas TAT-
HOXB4 resulted in a net expansion of 20-fold over con-
trol values. Again, this data could result from the toxicity-
dependent eﬀects of the GFP gene, used as the control for
gene transfer.
Availabilityofstable,long-termmarkedASCshasimpor-
tantapplicationsinadvancingASCresearch.Currently,there
are no exclusive ASC markers that allow for easy characteri-
zationandvalidation.OneexampleistheexpansionofHSCs
in culture, currently a major challenge in the ﬁeld of HSC
research. Although markers have been found that promote
enrichment of ASCs from speciﬁc tissues [29, 30], these are
not suﬃcient for determining their “stemness” in any gen-
eral sense. Currently, the main method used to establish the
“stemness” of an ASC population is transplantation of cells
into animals and subsequent determination of whether the
cells can regenerate damaged tissues.
In some tissue models, determining repopulation eﬃ-
ciency is simpler than in others. For bone marrow repopu-
lation studies, the output metric is reconstitution of viable8 Journal of Biomedicine and Biotechnology
recipient animals after donor cell transplant. Few ASC stud-
ies have this ideal feature of functional reconstitution. Most
of these studies depend on in situ cell histology to indicate
eﬀective tissue repopulation. Studies of this sort have led to
debates regarding issues of ASC plasticity [31]. If a faithful
cell marker is not tracked in transplanted ASCs, then uncer-
tainty arises; since it is not clear whether the transplanted
cells or host cells are responsible for the observed results. In
some tissue models, such as the liver, where the tissue has
the capacity for active proliferation, tracking of transplanted
cells is even more crucial. Our ﬁndings suggest that CFP and
YFP are better reporters for the development of stable, long-
term ﬂuorescence-expressing ASCs in culture. Their choice
for future ASC research may help to resolve current contro-
versial issues, including ASC plasticity in animal repopula-
tion assays.
Notwithstanding the current controversy regarding ASC
plasticity and cell fusion [31–33], our ﬁndings with GFP
call for reevaluation of conclusions based on the transduc-
tion of GFP-transgenes into manipulated ASC populations.
Additionally, our ﬁndings establish important quality con-
trol concepts for developing and implementing methods and
tools for future ASC therapeutics that employ gene transfer.
Our experience highlights the importance of careful in vit-
rocharacterization of genetically marked cell populations be-
fore in vivo transplantation.
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